| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 1 |
| 1 | ASPIRIN | 1 |
| 2 | ASPIRIN 325 MG | 1 |
| 3 | ASPIRIN 81 MG | 1 |
| 4 | DONANEMAB-AZBT | 1 |
| 5 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | 1 |
| 6 | HYDROXYUREA | 1 |
| 7 | INFLIXIMAB | 1 |
| 8 | INFLIXIMAB-DYYB | 1 |
| 9 | LECANEMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DONANEMAB-AZBT | 1 | 0.0003 |
| 1 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 2 | LECANEMAB | 1 | 0.0003 |
| 3 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | 1 | 0.0001 |
| 4 | HYDROXYUREA | 1 | 0.0000 |
| 5 | APIXABAN | 1 | 0.0000 |
| 6 | ROSUVASTATIN | 1 | 0.0000 |
| 7 | INFLIXIMAB | 1 | 0.0000 |
| 8 | ASPIRIN | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 1 | Factor Xa Inhibitor [EPC] | 1 | 0.0000 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |